{
  "id": "e20a9264c3919865",
  "title": "Foresee Pharmaceuticals announces Global Licensing Agreement for MMP - 12 Inhibitors with Primevera Therapeutics LLC",
  "description": "20260108T094500Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "http://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-global-licensing-agreement-for-mmp-12-inhibitors-with-primevera-therapeutics-llc-302656266.html",
  "published_at": "20260108T094500Z",
  "fetched_at": "2026-01-09T00:23:18.491015+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.prnewswire.com/news-releases/foresee-pharmaceuticals-announces-global-licensing-agreement-for-mmp-12-inhibitors-with-primevera-therapeutics-llc-302656266.html",
    "url_mobile": "",
    "title": "Foresee Pharmaceuticals announces Global Licensing Agreement for MMP - 12 Inhibitors with Primevera Therapeutics LLC",
    "seendate": "20260108T094500Z",
    "socialimage": "",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}